COLUMBUS, Ohio (WKBN) – Ohio will begin using a new tool in its fight against prescription drug abuse.
The State of Ohio Board of Pharmacy announced an upgrade to Ohio’s prescription drug monitoring program, known as the Ohio Automated Rx Reporting System (OARRS), that will provide Ohio prescribers and pharmacists with advanced analytics and tools to promote patient safety and assist in clinical decision-making.
The upgrade to OARRS, utilizing Appriss Health’s NarxCare® platform, offers several key features, including scores that calculate a patient’s possible risk of overdose and addiction, red flags to alert prescribers of a potential patient safety issue, interactive visualization of prescription data, a messaging option to communicate with other healthcare providers and the ability to search for local addiction treatment providers.
The new platform will be made available at no cost to all Ohio healthcare providers accessing OARRS via electronic health records and through the OARRS website on November 20, 2017.
“Ohio has been a national leader in tracking the dispensing of prescription drugs to patients,” said Ohio Department of Medicaid Medical Director Dr. Mary Applegate. “This upgraded drug monitoring platform will offer critical information to Ohio clinicians to help them provide better and safer treatment for their patients.”
Ohio has been strengthening its prescription drug monitoring program to give prescribers and pharmacists greater ability to prevent opiate abuse. As a result, doctor shopping – where individuals see multiple prescribers to obtain controlled substances illicitly – has decreased substantially and the total number of opiates dispensed to patients is down 20 percent over a four-year period. according to Ohio Board of Pharmacy.
Implementation of the upgrade is supported by the Health Information Technology for Economic and Clinical Health (HITECH) Act administered by the Centers for Medicare and Medicaid Services (CMS). More information on NarxCaree® is available online.